5-fluorouracil enhances the antitumor effect of sorafenib and sunitinib in a xenograft model of human renal cell carcinoma

Sorafenib and sunitinib are multi-kinase inhibitors with antitumor activity in patients with advanced renal cell carcinoma (RCC). Several studies have evaluated the effect of sorafenib/sunitinib in combination with chemotherapeutic agents in different types of tumor. However, few studies have addres...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncology letters 2012-06, Vol.3 (6), p.1195-1202
Hauptverfasser:	MIYAKE, MAKITO, ANAI, SATOSHI, FUJIMOTO, KIYOHIDE, OHNISHI, SAYURI, KUWADA, MASAOMI, NAKAI, YASUSHI, INOUE, TAKESHI, TOMIOKA, ATSUSHI, TANAKA, NOBUMICHI, HIRAO, YOSHIHIKO
Format:	Artikel
Sprache:	eng
Schlagworte:	5-fluorouracil angiogenesis renal cell carcinoma sorafenib sunitinib
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!